These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3261247)

  • 21. Chemoprotective effects of recombinant human IL-1 alpha in cyclophosphamide-treated normal and tumor-bearing mice. Protection from acute toxicity, hematologic effects, development of late mortality, and enhanced therapeutic efficacy.
    Futami H; Jansen R; MacPhee MJ; Keller J; McCormick K; Longo DL; Oppenheim JJ; Ruscetti FW; Wiltrout RH
    J Immunol; 1990 Dec; 145(12):4121-30. PubMed ID: 2258610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble murine IL-1 receptor type I induces release of constitutive IL-1 alpha.
    Netea MG; Kullberg BJ; Boerman OC; Verschueren I; Dinarello CA; Van der Meer JW
    J Immunol; 1999 Apr; 162(8):4876-81. PubMed ID: 10202032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
    Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
    Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decrease in interleukin 2-induced vascular leakage in the lungs of mice by administration of recombinant interleukin 1 alpha in vivo.
    Puri RK; Travis WD; Rosenberg SA
    Cancer Res; 1989 Feb; 49(4):969-76. PubMed ID: 2783561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis of phagocytic cells induced by Candida albicans and production of IL-10.
    Gasparoto TH; Gaziri LC; Burger E; de Almeida RS; Felipe I
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):219-24. PubMed ID: 15364107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta.
    Nabozny GH; Kong YC
    J Immunol; 1992 Aug; 149(3):1086-92. PubMed ID: 1634763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Enhancement of host defence against infection with Listeria monocytogenes in newborn mice by various recombinant cytokines].
    Chen Y
    Hokkaido Igaku Zasshi; 1991 Jan; 66(1):41-8. PubMed ID: 1900802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.
    Huang W; Na L; Fidel PL; Schwarzenberger P
    J Infect Dis; 2004 Aug; 190(3):624-31. PubMed ID: 15243941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-1 in vivo modulates trauma-induced immunosuppression.
    Lilic D; Kukic Z; Pejnovic N; Dujic A
    Eur Cytokine Netw; 1990; 1(3):149-56. PubMed ID: 2129799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection.
    Hazlett LD; Huang X; McClellan SA; Barrett RP
    Eye (Lond); 2003 Nov; 17(8):863-71. PubMed ID: 14631390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of oral administration of a traditional medicine, Juzen-Taiho-To, and its components on lethal Candida albicans infection in immunosuppressed mice.
    Abe S; Tansho S; Ishibashi H; Inagaki N; Komatsu Y; Yamaguchi H
    Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):421-31. PubMed ID: 9736446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1.
    Kullberg BJ; van 't Wout JW; van Furth R
    Infect Immun; 1990 Oct; 58(10):3319-24. PubMed ID: 2144844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Options for the treatment of serious infections with interleukin-1.
    van der Meer JW
    Biotherapy; 1989; 1(4):313-7. PubMed ID: 2701646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection.
    van der Meer JW
    Biotherapy; 1988; 1(1):19-25. PubMed ID: 3079457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum interleukin-6 levels in murine models of Candida albicans infection.
    Kovács R; Czudar A; Horváth L; Szakács L; Majoros L; Kónya J
    Acta Microbiol Immunol Hung; 2014 Mar; 61(1):61-9. PubMed ID: 24631754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of antibacterial resistance of neutropenic, bone marrow-suppressed mice by interleukin-1 alpha.
    McIntyre KW; Unowsky J; DeLorenzo W; Benjamin W
    Infect Immun; 1989 Jan; 57(1):48-54. PubMed ID: 2783314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No effect of recombinant human interleukin-1 on numbers of peripheral blood and peritoneal leukocytes during acute inflammation.
    Kullberg BJ; Van't Wout JW; van Furth R
    Inflammation; 1991 Dec; 15(6):457-70. PubMed ID: 1757129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination effect of recombinant human interleukin-1 alpha with antimicrobial agents.
    Nakamura S; Minami A; Fujimoto K; Kojima T
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1804-10. PubMed ID: 2589847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced antibacterial resistance in neutropenic mice treated with human recombinant interleukin-1 beta.
    Gladue R; Girard A; Newborg M
    Agents Actions; 1988 Jun; 24(1-2):130-6. PubMed ID: 3044030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candida tropicalis infection in normal, diabetic, and neutropenic mice.
    Fromtling RA; Abruzzo GK; Giltinan DM
    J Clin Microbiol; 1987 Aug; 25(8):1416-20. PubMed ID: 3624439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.